Denali Therapeutics Inc. · NASDAQ:DNLI
Baillie Gifford & Co reported a 7.50% stake in Denali Therapeutics Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 4, 2026
Baillie Gifford & Co reported a 7.50% stake in Denali Therapeutics Inc., 11,960,230 shares, as a passive investor on Jun 30, 2026. Filed Aug 4, 2026 (Schedule 13G/A).
- Stake
- 7.50%
- Shares
- 11,960,230
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BAILLIE GIFFORD & CO | 7.50% | 11,960,230 |
Source
Related
- Denali Therapeutics Inc.
- Baillie Gifford & Co
- Denali Therapeutics Inc. shareholders
- Schedule 13G · Baillie Gifford & Co · Aug 8, 2025
- Schedule 13G/A · Baillie Gifford & Co · Feb 12, 2025
- Schedule 13G/A · Baillie Gifford & Co · Feb 12, 2025
- Form 4 · Chin Peter Scott · Sep 9, 2026
- Form 4 · Thornberry Nancy · Sep 4, 2026
- Form 4 · Schuth Alexander O. · Sep 3, 2026
- Form 4 · Watts Ryan J. · Aug 14, 2026
- Form 4 · Schuth Alexander O. · Aug 13, 2026